Activated peripheral blood mononuclear cells from patients receiving subcutaneous interleukin-2 following autologous stem cell transplantation prolong survival of SCID mice bearing human lymphoma.

Katsanis, E

Activated peripheral blood mononuclear cells from patients receiving subcutaneous interleukin-2 following autologous stem cell transplantation prolong survival of SCID mice bearing human lymphoma. [electronic resource] - Bone marrow transplantation Jul 1998 - 185-91 p. digital

Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.

0268-3369

10.1038/sj.bmt.1701307 doi


Administration, Cutaneous
Animals
Hematopoietic Stem Cell Transplantation
Humans
Immunotherapy, Adoptive
Interleukin-2--administration & dosage
Killer Cells, Natural--immunology
Lymphoma, B-Cell--blood
Mice
Mice, SCID
Neoplasms, Experimental--immunology
Transplantation, Autologous